Temasek's $6.5 Billion Investment Paves the Way for European Expansion Through Swiss Pharma Merger

In a significant move that highlights the growing interest of Asian investors in the European market, Singapore’s sovereign wealth fund, Temasek, has unveiled a groundbreaking merger in the pharmaceutical sector worth $6.5 billion. This strategic alliance marks Temasek's ambitious foray into Europe, aiming to capitalize on the continent's robust healthcare landscape.

Continue reading